Summary
The product Bulk Blend 350, manufactured by Unique Pharma, underwent independent testing to verify its composition and potency. The sample, identified by batch number UN56438, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of three active ingredients:
- Testosterone Enanthate: 141.75 mg/ml
- Drostanolone Enanthate: 75.31 mg/ml (noting a 20% margin of error due to interference)
- Trenbolone Enanthate: 92.90 mg/ml
The testing process began on 26 September 2022, with the sample received on 1 October 2022, and the analysis completed on 14 October 2022. While the results confirm the presence of the listed ingredients, the margin of error for Drostanolone Enanthate suggests potential variability. As with all reseller-submitted samples, independent verification is recommended to ensure consistent quality across different batches.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: Bulk Blend 350
- Active Ingredients:
- Testosterone Enanthate
- Drostanolone Enanthate
- Trenbolone Enanthate
- Batch Number: UN56438
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #24392
- Testing Ordered: 26 September 2022
- Sample Received: 1 October 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: Bulk Blend 350 (claimed total concentration 350 mg/ml)
- Measured Concentrations:
- Testosterone Enanthate: 141.75 mg/ml
- Drostanolone Enanthate: 75.31 mg/ml (±20% margin of error due to interference)
- Trenbolone Enanthate: 92.90 mg/ml
- Total Measured Concentration: 309.96 mg/ml (excluding margin of error)
- Variance: 11.44% below the claimed total concentration
Verification Details
- Verification URL: www.janoshik.com/tests/24392_W81L3QT17WUF
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
This analysis confirms the presence of the listed active ingredients; however, the noted margin of error for Drostanolone Enanthate raises concerns about accuracy. Reseller-submitted samples, such as this one from Opitropin.EU, may represent high-quality batches selected for favorable results. Therefore, third-party validation across multiple batches is recommended to ensure consistency across the entire product line.
Conclusion
The analysis of Bulk Blend 350 indicates an overall measured concentration of 309.96 mg/ml, which is slightly below the claimed total concentration of 350 mg/ml. While the product appears to meet general expectations, the noted variance highlights the need for further independent testing to ensure consistency. This report is provided as an educational resource to aid consumers in making informed decisions.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may introduce inherent biases, but it still provides useful data when critically assessed alongside third-party results. Consumers should interpret this information responsibly and consider additional verification.ing is recommended to ensure product quality and reliability.
